Stocks TelegraphStocks Telegraph
Stock Ideas

QGEN Company Profile and Key Details

NYSE : QGEN

Qiagen NV

$51.23
-0.48-0.93%
At Close 4:00 PM
55.16
B-ESG ScoreESG Rating

Price Chart

Stock Price Today

Qiagen N.V. (QGEN) stock declined over -0.93%, trading at $51.23 on NYSE, down from the previous close of $51.71. The stock opened at $49.91, fluctuating between $49.37 and $53.30 in the recent session.

Stock Snapshot

51.71
Prev. Close
10.55B
Market Cap
49.365
Day Low
26.27
P/E Ratio
1.95
EPS (TTM)
1.34
Cash Flow per Share
49.91
Open
206M
Number of Shares
53.3
Day High
99.52%
Free Float in %
17.2
Book Value
5.98M
Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing DateAccepted Date

Annual Report (10-k)

Filing DateAccepted Date

Stock Price History Chart

DateOpenHighLowCloseVolume
Feb 05, 202649.9153.3049.3751.235.98M
Feb 04, 202652.2052.2051.4051.712.37M
Feb 03, 202651.9152.3051.2551.892.84M
Feb 02, 202652.4553.0351.7752.181.77M
Jan 30, 202653.2953.7852.7553.671.74M
Jan 29, 202653.7754.1052.6153.713.15M
Jan 28, 202653.5354.0053.1853.992.86M
Jan 27, 202654.5154.9853.9854.222.51M
Jan 26, 202655.4856.1954.0054.222.46M
Jan 23, 202653.4655.6653.4455.624.32M
Jan 22, 202654.7255.1253.8854.254.21M
Jan 21, 202654.1155.7153.7555.668.72M
Jan 20, 202646.2057.8246.0755.4515.02M
Jan 07, 202649.6050.0749.2549.801.61M
Jan 06, 202648.7949.8848.7949.481.61M
Jan 05, 202647.4649.0347.3948.943.07M
Jan 02, 202647.3347.7047.0647.571.15M
Dec 31, 202547.6147.7947.2847.34503.89K
Dec 30, 202547.7947.9447.5447.71748.5K
Dec 29, 202548.2848.4447.8348.00997.91K

Contact Details

Venlo, 5912 PL

Netherlands

https://www.qiagen.com317 735 56600

About Company

QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, including kits and components for purification of nucleic acids from secondary sample materials; and instruments for nucleic acid purification and accessories. It also provides interferon-gamma release assay for TB testing, and assays for post-transplant testing and viral load monitoring; assays for prenatal testing and detection of sexually transmitted diseases and HPV, as well as assays for analysis of genomic variants, such as mutations, insertions, deletions, and fusions; and sample to insight instruments, including one-step molecular analysis of hard-to-diagnose syndromes, and integrated PCR testing. In addition, it offers PCR consumables, such as quantitative PCR, reverse transcription, and combinations kits for analysis of gene expression, genotyping, and gene regulation instruments and technologies; human ID and forensics assay consumables, including STR assays for human ID, and assays for food contamination; PCR instruments consist of digital PCR solutions; and developed and configured OEM consumables. Further, the company provides predefined and custom NGS gene panels, library prep kits and components, and whole genome amplification; QIAGEN consumables and instruments, as well as bioinformatics solutions; and custom laboratory and genomic services. It serves molecular diagnostics, academia, pharmaceutical, and applied testing customers. It has a strategic alliance agreement with Sysmex Corporation and OncXerna Therapeutics, as well as an agreement with Mirati. The company was founded in 1986 and is headquartered in Venlo, the Netherlands.

Company Information

Employees5700
Beta0.66
Sales or Revenue$1.97B
5Y Sales Change%0.333%
Fiscal Year EndsDecember
SectorHealthcare
IndustryMedical - Diagnostics & Research

Technical Performance

QGEN has shown sold momentum, gaining 17.35% over the past week and 14.99% over the past quarter, though year-to-date performance is up 23.43%. Short-term trend indicators are bearishly aligned (SMA20 -0.75%, SMA50 6.02%, SMA200 9.43%). The stock’s 14-day RSI is 52.39 (neutral), while the ATR of 1.74 points to higher daily volatility. The stock remains sitting in the mid-range of its 52-week band, trading -11.39% below its high and over 36.28% above its low. Average 10-day trading volume of 2.90 million shares is significantly above the 3-month average of 1.92 million, indicating heightened recent market interest.

Dividend & Fair Value

Qiagen N.V. last paid a dividend of 0.26 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $59.90. This means the shares are trading below this model’s fair value.

Earnings & Analyst Outlook

Wall Street analysts project EPS growth of 9.04% annually over the next five years. The latest quarter delivered EPS of $0.61. The next quarter is forecast at $0.58. Next year's EPS is expected at $3.73. Analyst sentiment is neutral. Analyst rating data shows there are 3 Strong Buy ratings, 1 Buy ratings, 5 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $55.00 to $42.00. The high target offers 7.36% upside. The low target suggests -18.02% downside. The mean target is $51.67. This offers 0.86% upside. Qiagen N.V. earnings surprise history is a consistent trend of beating forecasts. The quarter that ended November 04, 2025, missed forecasts by 5.17%. The prior quarter beat by 0.0%. Over the last six quarters, Apple has recorded several small beats. These include 5.77% in July 31, 2024.

Shareholding & Insider Activity

Qiagen N.V. has 216.83 million shares outstanding. The public float is 214.89 million shares, elevated short interest at 4.60% of float. This equals 6.72 million shares. The short ratio is 4.57 days. Institutional investors hold 88.78% of the float. Insiders own 1.61%.

Frequently Asked Questions

What is the current Qiagen N.V. (QGEN) stock price?
Qiagen N.V. (NYSE: QGEN) stock price is $51.23 in the last trading session. During the trading session, QGEN stock reached the peak price of $53.30 while $49.37 was the lowest point it dropped to. The percentage change in QGEN stock occurred in the recent session was -0.93% while the dollar amount for the price change in QGEN stock was - $0.48.
QGEN's industry and sector of operation?
The NYSE listed QGEN is part of Medical - Diagnostics & Research industry that operates in the broader Healthcare sector. Qiagen N.V. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Who are the executives of QGEN?
Dr. Jonathan G. Sheldon Ph.D.
Senior Vice President of Qiagen Digital Insights Bus. Area
Dr. Roland Sackers
Chief Financial Officer, MD & Member of Management Board
Mr. Thierry Bernard
Chief Executive Officer, MD & Member of Management Board
Mr. Thomas Neidert
Vice President of Global Treasury
Mr. John Gilardi
Vice President of Corporation Communications & Investor Relations
Ms. Stephany Foster
Senior Vice President & Head of HR
Dr. Thomas Theuringer
Senior Director & Head of External Communications
Mr. Jean-Pascal Viola
Senior Vice President & Head of Molecular Diagnostics Bus. Area
Mr. Antonio Santos
Senior Vice President & Head of Global Operations
Dr. Thomas Schweins
Senior Vice President of Life Science Bus. Area
How QGEN did perform over past 52-week?
QGEN's closing price is 36.14% higher than its 52-week low of $37.63 where as its distance from 52-week high of $57.82 is -11.4%.
How many employees does QGEN have?
Number of QGEN employees currently stands at 5,700.
Link for QGEN official website?
Official Website of QGEN is: https://www.qiagen.com
How do I contact QGEN?
QGEN could be contacted at phone 317 735 56600 and can also be accessed through its website. QGEN operates from Hulsterweg 82, Venlo, 5912 PL, Netherlands.
How many shares of QGEN are traded daily?
QGEN stock volume for the day was 5.98M shares. The average number of QGEN shares traded daily for last 3 months was 1.89M.
What is the market cap of QGEN currently?
The market value of QGEN currently stands at $10.55B with its latest stock price at $51.23 and 206M of its shares outstanding.
logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph